333
Participants
Start Date
March 31, 2004
Primary Completion Date
September 30, 2007
Study Completion Date
October 31, 2008
Cavilon (TM) Durable Barrier Cream
Cavilon (TM) Durable Barrier Cream will be applied to either the medial or the lateral side of the treated breast. Side will depend on randomisation.
Sorbolene
Sorbolene will be applied to either the medial or the lateral side of the treated breast. Side will be determined by randomisation
Radiotherapy
Minimum prescribed dose to the chest wall is 45Gy in 25 fractions. Planning and Treatment is per the study protocol
Liverpool Hospital, Liverpool
Prince of Wales Hospital, Randwick
Westmead Hospital, Wentworthville
St George Hospital, Kogarah
Calvary Mater Newcastle, Newcastle
Andrew Love Cancer Care Centre, Geelong Hospital, Geelong
Royal Brisbane Hospital, Herston
Mater QRI, South Brisbane
Princess Alexandra Hospital, Woolloongabba
Royal Adelaide Hospital, Adelaide
Royal Perth Hospital, Perth
Wollongong Hospital, Wollongong
3M
INDUSTRY
Trans Tasman Radiation Oncology Group
OTHER